Cargando...
Neuroleptic malignant syndrome in a patient with stable dose of olanzapine
Neuroleptic malignant syndrome (NMS), a potentially fatal consequence due to typical neuroleptics, has been described so far. In the past few years, there has been increased use of atypical antipsychotic drugs. Cases of NMS related to atypical neuroleptics, such as olanzapine, are less common in spi...
Guardado en:
| Publicado en: | J Family Med Prim Care |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5629885/ https://ncbi.nlm.nih.gov/pubmed/29026773 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2249-4863.214969 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|